Use of Cerebrospinal Fluid Shunts in Patients Having Acquired Immunodeficiency Syndrome with Cryptococcal Meningitis and Uncontrollable Intracranial Hypertension

Abstract

Patients with acquired immunodeficiency syndrome who develop cryptococcal meningitis and who suffer serious visual loss or ocular palsies with elevated pressures should be considered for cerebrospinal fluid shunting at an early stage.